Latest Working Capital News

Paladin Energy has restructured its syndicated debt facility, reducing total debt capacity from US$150 million to US$110 million, enhancing liquidity and balance sheet flexibility following a strong equity raise in 2025.

The Calmer Co. International Limited has completed a $1.4 million convertible note raise, positioning itself to accelerate wholesale growth and inventory build ahead of 2026.

ActivEX Limited has raised $100,000 through a strategic share placement to Business Victor Investments, aiming to accelerate its exploration projects and strengthen working capital.

Truscott Mining Corporation has initiated a $1.44 million capital raise through a share placement accompanied by unlisted options, aiming to bolster its exploration and development efforts.

Neurotech International has locked in $4 million through a share placement to advance its promising paediatric neurological drug, NTI164. The raise, supported by both new and existing investors including company directors, aims to fund critical clinical and regulatory milestones.

Cassius Mining Limited has raised $1.16 million through a share placement to fund its Soalara project in Madagascar and support ongoing litigation in Ghana.

Epiminder Limited has settled a $15.77 million tax liability with the ATO related to historical R&D claims, freeing up $4.23 million from IPO proceeds for working capital.

Audalia Resources is set to raise $540,000 through a share placement to fund critical development stages of its Medcalf Project and bolster working capital.

Elsight Limited has landed a substantial US$21.2 million contract for early 2026 deliveries, marking a dramatic increase in forward orders and reinforcing its role in the global defence and uncrewed systems sector.

Talga Group launches a $5 million Share Purchase Plan at a discounted price of $0.41 per share, offering eligible shareholders free attaching options as it advances its battery anode production expansion.

Talga Group has opened a $5 million Share Purchase Plan at $0.41 per share, offering shareholders free attaching and piggyback options to support its planned anode production ramp-up and US expansion.

Epsilon Healthcare reported a 19% revenue increase to $3.4 million for the half year ended June 2025, driven by new client wins and its pharmacy segment launch. However, net losses widened 44% to $2.07 million, reflecting administration and financing costs during its recovery phase.